Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection

<div>EOTR and SVR12. (a) EOTR and SVR12 in patients with different genotype. (b) EOTR and SVR12 in patients with different diagnosis. (c) EOTR and SVR12 in patients with different treatment plan.</div>

Canadian Journal of Gastroenterology and Hepatology

fig2

Figure 2

Figure 2: Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection 

Figure 2 | Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection 